JNJ

227.58

+1.12%↑

UNH

366.5

+3.49%↑

TMO

470.15

+0.34%↑

ISRG

466.67

-0.89%↓

ABT

93.81

+1.03%↑

JNJ

227.58

+1.12%↑

UNH

366.5

+3.49%↑

TMO

470.15

+0.34%↑

ISRG

466.67

-0.89%↓

ABT

93.81

+1.03%↑

JNJ

227.58

+1.12%↑

UNH

366.5

+3.49%↑

TMO

470.15

+0.34%↑

ISRG

466.67

-0.89%↓

ABT

93.81

+1.03%↑

JNJ

227.58

+1.12%↑

UNH

366.5

+3.49%↑

TMO

470.15

+0.34%↑

ISRG

466.67

-0.89%↓

ABT

93.81

+1.03%↑

JNJ

227.58

+1.12%↑

UNH

366.5

+3.49%↑

TMO

470.15

+0.34%↑

ISRG

466.67

-0.89%↓

ABT

93.81

+1.03%↑

Home・Akciju saraksts・Omnicell Inc

Omnicell Inc

Slēgts

SektorsVeselības aprūpe

45.33 20.78

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

37.6

Max

46.38

Galvenie mērījumi
By Trading Economics
Ienākumi	-7.5M -2M
Pārdošana	3.4M 314M
P/E Sektora vidējais	940.75 67.147
Peļņas marža	-0.645
Darbinieki	3,580
EBITDA	-9.8M 21M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+61.57% upside

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-526M 1.7B
Iepriekšējā atvēršanas cena	24.55
Iepriekšējā slēgšanas cena	45.33

Ziņu noskaņojums

By Acuity

14%

86%

25 / 348 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bearish Evidence

24.23 / 30.44 Atbalsts un pretestība

Omnicell Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 28. apr. 23:33 UTC

Karstas akcijas

Stocks to Watch: Robinhood, Visa, Seagate Technology, NXP Semiconductors

2026. g. 28. apr. 23:24 UTC

Peļņas

Visa 2Q Revenue Climbs as Consumers Keep Spending; Board Authorizes $20 Billion Buyback -- Update

2026. g. 28. apr. 23:15 UTC

Galvenie ziņu notikumi

U.K. Economy to Suffer Large Loss of Output, Higher Inflation as Result of Middle East Conflict

2026. g. 28. apr. 22:46 UTC

Peļņas

Booking Holdings Cuts Outlook as Middle East Conflict Weighs on Travel Demand -- Update

2026. g. 28. apr. 22:37 UTC

Peļņas

Prudential PLC 1Q New Business Profit $686.0 Million, Up 10% on Year

2026. g. 28. apr. 22:15 UTC

Peļņas

Galvenie ziņu notikumi

Mondelez Reports Developing Market Growth Offsetting U.S., Europe Weakness -- Update

2026. g. 28. apr. 23:33 UTC

Tirgus saruna

Galvenie ziņu notikumi

Gold Edges Lower on Prospects of Dollar Strength -- Market Talk

2026. g. 28. apr. 23:31 UTC

Peļņas

China Petroleum & Chemical 1Q Net Rose on Higher Crude Oil Prices >0386.HK

2026. g. 28. apr. 23:31 UTC

Peļņas

China Petroleum & Chemical 1Q Capex Was CNY25.17B >0386.HK

2026. g. 28. apr. 23:30 UTC

Peļņas

China Petroleum & Chemical 1Q Net CNY17.74B Vs. Net CNY13.98B >0386.HK

2026. g. 28. apr. 23:30 UTC

Peļņas

China Petroleum & Chemical 1Q Rev CNY706.70B Vs. CNY735.36B >0386.HK

2026. g. 28. apr. 23:19 UTC

Tirgus saruna

Peļņas

Visa Points to Spending Boost from Tax Refunds in U.S. -- Market Talk

2026. g. 28. apr. 23:09 UTC

Peļņas

Visa 2Q Revenue Climbs as Consumers Keep Spending; Board Authorizes $20B Buyback -- Update

2026. g. 28. apr. 23:03 UTC

Tirgus saruna

Australia's Inflation Outlook Looks Pretty Grim -- Market Talk

2026. g. 28. apr. 23:01 UTC

Galvenie ziņu notikumi

NIESR Sees One Rate Rise to 4% in Benign Scenario

2026. g. 28. apr. 23:01 UTC

Galvenie ziņu notikumi

NIESR Sees U.K. Economy Growing by Just 0.5% in 'Adverse' Middle East Scenario

2026. g. 28. apr. 23:01 UTC

Galvenie ziņu notikumi

NIESR: BOE's Key Rate Should Rise to 5.25% in Adverse Scenario

2026. g. 28. apr. 23:01 UTC

Galvenie ziņu notikumi

U.K.'s NIESR Lowers 2026 U.K. Economic Growth Forecast to 0.9% From 1.4% in 'Benign' Scenario

2026. g. 28. apr. 23:01 UTC

Galvenie ziņu notikumi

NIESR Sees Inflation Peaking at Over 6% in Adverse Scenario

2026. g. 28. apr. 22:51 UTC

Peļņas

Robinhood Earnings Fall Short. A Crypto Slump Is the Culprit. -- Barrons.com

2026. g. 28. apr. 22:48 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 28. apr. 22:48 UTC

Tirgus saruna

Australia's 1Q CPI Will Likely Provide Little Relief For RBA -- Market Talk

2026. g. 28. apr. 22:40 UTC

Tirgus saruna

Galvenie ziņu notikumi

Australian 1Q CPI Will Likely Keep May Hike Alive -- Market Talk

2026. g. 28. apr. 22:32 UTC

Peļņas

Booking Beats on Profit. Travel Demand Outlook Clouded By Iran War. -- Barrons.com

2026. g. 28. apr. 22:25 UTC

Iegādes, apvienošanās, pārņemšana

Pernod Ricard and Brown-Forman End Deal Talks -- Update

2026. g. 28. apr. 22:22 UTC

Peļņas

Prudential PLC 1Q New Business Profit $686.0M, Up 10% on Year

2026. g. 28. apr. 22:17 UTC

Tirgus saruna

Canada Fiscal Update Puts Central Bank on Track to Raise Rates -- Market Talk

2026. g. 28. apr. 22:14 UTC

Peļņas

Prudential PLC 1Q APE Sales Up 6% on Year, to $1.823B >2378.HK

2026. g. 28. apr. 22:14 UTC

Peļņas

Prudential PLC 1Q New Business Profit $686.0M, Up 10% on Year >2378.HK

2026. g. 28. apr. 22:07 UTC

Tirgus saruna

Galvenie ziņu notikumi

Canada Chamber Frets Over Lost Fiscal Room -- Market Talk

Salīdzinājums

Cenas izmaiņa

Omnicell Inc Prognoze

Cenas mērķis

By TipRanks

61.57% augšup

Prognoze 12 mēnešiem

Vidējais 60.8 USD 61.57%

Augstākais 70 USD

Zemākais 49 USD

Pamatojoties uz 7 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Omnicell Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

7 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 7 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Omnicell Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

24.23 / 30.44Atbalsts un pretestība

Recent bearish events outweigh bullish events.

All events are bearish.

Noskaņojums

By Acuity

25 / 348 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.